UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-26 | Future report Set alerts | |
| Q2 2022 | 2022-08-04 | -0.13 | -0.13 |
| Q1 2022 | 2022-05-05 | 0.00 | 0.00 |
| Q4 2021 | 2022-02-24 | -0.03 | -0.03 |
| Q3 2021 | 2021-10-28 | 0.07 | 0.07 |
| Q2 2021 | 2021-07-29 | 0.11 | 0.11 |
| Q1 2021 | 2021-05-05 | 0.14 | 0.14 |
| Q4 2020 | 2021-02-24 | 0.08 | 0.08 |
| Q3 2020 | 2020-10-29 | 0.10 | -0.06 |
| Q2 2020 | 2020-08-04 | 0.04 | -0.15 |
| 2016-06-15 | Reiterated Rating | Piper Jaffray | Overweight | $6.00 |
| 2016-06-15 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $6.00 |
| 2016-06-14 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-06-14 | Boost Price Target | Mizuho | Buy | $8.00 to $12.00 |
| 2016-04-21 | Reiterated Rating | Leerink Swann | Buy | $8.00 to $7.00 |
| 2016-04-21 | Reiterated Rating | Piper Jaffray | Overweight | $8.00 to $6.00 |
| 2016-03-29 | Reiterated Rating | Leerink Swann | Outperform | $8.00 |
| 2016-02-09 | Initiated Coverage | Janney Montgomery Scott | Buy to Buy | $12.00 |
| 2015-11-18 | Boost Price Target | Craig Hallum | Buy | $10.00 to $13.00 |
| 2015-09-28 | Downgrade | Raymond James | Outperform to Market Perform | |
| 2015-09-28 | Downgrade | Raymond James Financial Inc. | Outperform to Market Perform | |
| 2015-09-25 | Initiated Coverage | Craig Hallum | Buy | $13.00 |
| 2015-08-14 | Reiterated Rating | Leerink Swann | Outperform | $10.00 |
| 2015-05-13 | Lower Price Target | Raymond James | Outperform | $8.00 to $6.50 |
| 2015-03-18 | Set Price Target | Piper Jaffray | Buy | $8.00 |
| 2015-03-18 | Lower Price Target | Mizuho | Buy | $15.00 to $12.00 |
| 2014-08-11 | Initiated Coverage | Piper Jaffray | Overweight | $13.00 |
| 2014-08-11 | Initiated Coverage | Raymond James | Outperform | $12.50 |
| 2014-08-11 | Initiated Coverage | Leerink Swann | Outperform | $13.00 |
| 2014-08-11 | Initiated Coverage | Mizuho | Buy | $13.28 to $15.00 |
| 2016-06-15 | Reiterated Rating | Piper Jaffray | Overweight | $6.00 |
| 2016-06-15 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $6.00 |
| 2016-06-14 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-06-14 | Boost Price Target | Mizuho | Buy | $8.00 to $12.00 |
| 2016-04-21 | Reiterated Rating | Leerink Swann | Buy | $8.00 to $7.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CDNA 141 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 5.07M |
| STATE STREET CORP | 4.25M |
| BlackRock Inc. | 4.01M |
| Arrowpoint Asset Management, LLC | 3.09M |
| Nikko Asset Management Americas, Inc. | 2.49M |
| Sumitomo Mitsui Trust Holdings, Inc. | 2.49M |
| FRED ALGER MANAGEMENT INC | 1.98M |
| Clearbridge Investments, LLC | 1.66M |
| BAMCO INC /NY/ | 1.62M |
| MACQUARIE GROUP LTD | 1.60M |
| WADDELL & REED FINANCIAL INC | 1.53M |
| GAGNON SECURITIES LLC | 1.29M |
| CREDIT SUISSE AG/ | 1.23M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.94M |
| D. E. Shaw & Co., Inc. | 0.88M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| TPG Group Holdings (SBS) Advisors, Inc. | 9.12% (1075090) | AERI / ALDR / CDNA / CZR / EPRS / FSL / GPK / IMS / LPLA / MGNX / NCLH / NTI / OTIC / PKY / Q / ROKA / SABR / SCAI / SUP / TIPT / TMHC / TNDM / VCYT / ZMH / |
| GAGNON NEIL | 8.19% (965894) | AMBR / AMRC / CDNA / GFN / NTS / |
| KLEINER PERKINS CAUFIELD & BYERS X A LP | 6.37% (751174) | CDNA / |
| Maag Peter See Remarks | 2.31% (272037) | CDNA / |
| Goldberg Michael | 1.07% (126123) | CDNA / EHTH / |
| Nelles Mitchell J Chief Operating Officer | 0.70% (82135) | CDNA / |
| SNYDERMAN RALPH | 0.54% (63799) | ARGS / CDNA / IRTC / TRGT / |
| LUDLUM KEN Chief Financial officer | 0.41% (48000) | BABY / CDNA / |
| Bickerstaff George | 0.39% (46007) | ARIA / CDNA / INO / THRX / |
| Yee James P Chief Medical Officer | 0.37% (43102) | CDNA / |
| HAGSTROM WILLIAM A | 0.29% (34532) | CDNA / |
| Cohen Fred E | 0.28% (32901) | BCRX / CDNA / FPRX / GHDX / ROKA / TNDM / VCYT / |
| Sninsky John Joseph Chief Scientific Officer | 0.20% (23114) | CDNA / |
| Meyer Matthew J. Chief Business Officer | 0.20% (23025) | CDNA / |
| BYERS BROOK H | 0.19% (21912) | CDNA / FMI / PACB / VCYT / |
| Whitson Todd Chief Commercial Officer | 0.17% (20000) | CDNA / |
| MILLER DOUGLAS S | 0.15% (17695) | CDNA / PKT / TNAV / |
| Bell Michael Brian Chief Financial Officer | 0.12% (14738) | CDNA / |
| DeFonzo Joshua Chief Commercial Officer | 0.09% (11000) | CDNA / |
| Constanti Charles Chief Financial Officer | 0.08% (10000) | CDNA / PKT / |
| Karlsson Anders See Remarks | 0.08% (9638) | CDNA / |
UM